Business Type:Manufacturer
Main Products:antidiabetes intermediates,antidepression intermediates,anticoagulation intermediates,Antiepileptics intermediates,(S)-2-aminobutanamide hydrochloride,vildagliptin intermediates,Glimepride intermdiates,Teneligliptin intermediates,Linagliptin intermediates,Canagliflozin intermediates
Country/Region:China
Annual Revenue:2500000 USD
Year Established:2003
Main Markets:North America,Eastern Europe,Southeast Asia,Mid East,Eastern Asia,Western Europe,
Ddu Verified
HOT Rank
8/10